The Effect of ShotBlocker on Pain and Satisfaction During Measles-Rubella-Mumps Vaccination
NCT ID: NCT06762938
Last Updated: 2025-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2024-08-01
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Method. The study was conducted in a Family Health Center affiliated to the Public Health Directorate of a province in eastern Turkey between August and October 2024 using a randomized controlled experimental design. The study sample consisted of 60 infants who received MMR vaccination (ShotBlocker group: n = 30, control group: n = 30). Infants in the ShotBlocker group received ShotBlocker before vaccine injection, while infants in the control group received only routine vaccine injection. Infant information form, FLACC pain scale and Newcastle Satisfaction with Nursing Care Scale were used for data collection. Ethical principles were followed throughout the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?
NCT04445610
Measles Vaccine in HCW
NCT04357028
Intervention to Promote Childhood Vaccinations and Influence Vaccination Attitudes
NCT05425823
Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial
NCT02904642
A Second Dose of Measles Vaccine (MV) in the Second Year of Life
NCT02943681
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ShotBlocker
ShotBlocker
Apply ShotBlocker
Control
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ShotBlocker
Apply ShotBlocker
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* MMR vaccine will be administered,
* growth-development is normal,
* no analgesic medication was given during the day,
* at least high school graduate
* mothers who volunteered to participate in the study
Exclusion Criteria
* a chronic disease,
* allergy (egg allergy)
* infants with symptoms of hyperthermia
12 Months
12 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yuzuncu Yıl University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Veysel Can
Asst. Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Van Yüzüncü Yıl University
Van, Tuşba, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ShotBlocker
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.